McKesson Shares Outstanding 2006-2018 | MCK

Current and historical number of shares outstanding for McKesson (MCK) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
McKesson Annual Shares Outstanding
(Millions of US $)
2018 $209
2017 $223
2016 $233
2015 $235
2014 $233
2013 $239
2012 $251
2011 $263
2010 $273
2009 $279
2008 $298
2007 $305
2006 $316
2005 $294
McKesson Quarterly Shares Outstanding
(Millions of US $)
Q1 2018 $202
Q4 2018 $209
Q3 2017 $208
Q2 2017 $210
Q1 2017 $213
Q4 2017 $223
Q3 2016 $222
Q2 2016 $228
Q1 2016 $228
Q4 2016 $233
Q3 2015 $232
Q2 2015 $235
Q1 2015 $235
Q4 2015 $235
Q3 2014 $236
Q2 2014 $235
Q1 2014 $235
Q4 2014 $233
Q3 2013 $234
Q2 2013 $233
Q1 2013 $232
Q4 2013 $239
Q3 2012 $240
Q2 2012 $240
Q1 2012 $240
Q4 2012 $251
Q3 2011 $251
Q2 2011 $250
Q1 2011 $254
Q4 2011 $263
Q3 2010 $258
Q2 2010 $262
Q1 2010 $272
Q4 2010 $273
Q3 2009 $274
Q2 2009 $271
Q1 2009 $272
Q4 2009 $279
Q3 2008 $274
Q2 2008 $280
Q1 2008 $282
Q4 2008 $298
Q3 2007 $297
Q2 2007 $299
Q1 2007 $304
Q4 2007 $305
Q3 2006 $302
Q2 2006 $305
Q1 2006 $309
Q4 2006 $316
Q3 2005 $316
Q2 2005 $316
Q1 2005 $313
Q4 2005 $294
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.600B $208.357B
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $66.712B 23.88
Align Technology (ALGN) United States $29.279B 78.06
Laboratory Of America Holdings (LH) United States $18.300B 16.83
AmerisourceBergen (ABC) United States $17.737B 12.89
Cardinal Health (CAH) United States $15.037B 10.08
Cooper (COO) United States $12.436B 23.15
Henry Schein (HSIC) United States $11.846B 20.20
DENTSPLY SIRONA (XRAY) United States $8.676B 15.18
West Pharmaceutical Services (WST) United States $8.444B 43.66
Merit Medical Systems (MMSI) United States $2.997B 39.39
CONMED (CNMD) United States $2.148B 36.39
Patterson (PDCO) United States $2.134B 13.36
STAAR Surgical (STAA) United States $1.676B 235.00
Atrion (ATRI) United States $1.180B 34.99
Invacare (IVC) United States $0.555B 0.00
Antares Pharma (ATRS) United States $0.456B 0.00
Endologix (ELGX) United States $0.253B 0.00
Lifevantage (LFVN) United States $0.161B 33.32
Aceto (ACET) United States $0.097B 3.92
Pro-Dex (PDEX) United States $0.029B 12.89
Biolase (BIOL) United States $0.028B 0.00
Milestone Scientific (MLSS) United States $0.028B 0.00
Retractable Technologies (RVP) United States $0.025B 0.00